← Open Payments lookup

CHLOE HORVATH: Open Payments

NPI 1669874103 · ANNAPOLIS, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$767 in 31 payments from 13 companies in 2025. Trend: 2023 $233 · 2024 $805 · 2025 $767

Food & beverage: $767
CompanyPaymentsAmount
Novo Nordisk Inc5$144
AstraZeneca Pharmaceuticals LP2$144
PFIZER INC.5$115
Novartis Pharmaceuticals Corporation5$87
Actelion Pharmaceuticals US, Inc.3$74
Esperion Therapeutics, Inc.2$42
E.R. Squibb & Sons, L.L.C.2$38
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)2$25
GlaxoSmithKline, LLC.1$22
Bayer Healthcare Pharmaceuticals Inc.1$20

Products named: Wegovy, LOKELMA, VYNDAQEL, LEQVIO, NEXLETOL, CAMZYOS, OPSYNVI, LifeVest.

Industry payments across MD — which companies pay providers there.